26.06.2007 13:00:00
|
Landec Corporation Added to the Russell 3000 Index
Landec Corporation (Nasdaq: LNDC), a developer and marketer of patented
polymer products for food, agriculture and licensed partner
applications, announced today that its stock has been added to the
Russell 3000® Index,
effective June 25, 2007.
The annual reorganization process for the Russell U.S. indexes
identifies the largest 3,000 U.S. stocks, ranking them by total market
capitalization as of the end of May, and these companies become the
Russell 3000. The largest 1,000 companies in this index comprise the
Russell 1000® and the next 2,000 companies
comprise the Russell 2000®. The Russell 3000
serves as the U.S. component to the Russell Global Index, which Russell
launched earlier this year. Membership in the Russell 3000 remains in
place for one year. Landec’s addition to the
Russell 3000 means inclusion in the Russell 2000 as well as in the
appropriate growth and investment style indexes.
"We are pleased that Landec has been added to
the Russell 3000, which reflects Landec’s
continuing progress in operating results and in market value, while
increasing our exposure to a broader investment community,”
commented Gary Steele, President and Chief Executive Officer of Landec.
About Russell Investment Group
Russell Investment Group provides strategic advice, world-class
implementation, state-of-the-art performance benchmarks, and a range of
institutional-quality investment products. With more than $200 billion
in assets under management, Russell serves individual, institutional and
advisor clients in more than 40 countries. Russell determines membership
for its equity indexes primarily by objective, market-capitalization
rankings and style attributes. Founded in 1936, Russell is a subsidiary
of Northwestern Mutual Life Insurance Company. For more information on
Russell indexes, go to www.russell.com.
About Landec
Landec Corporation designs, develops, manufactures and sells
temperature-activated and other specialty polymer products for a variety
of food, agricultural and licensed partner applications. The Company's
temperature-activated polymer products are based on its proprietary
Intelimer® polymers which differ from other
polymers in that they can be customized to abruptly change their
physical characteristics when heated or cooled through a pre-set
temperature switch. For more information about Landec, visit Landec’s
website at www.landec.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
29.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor 3 Jahren eingebracht (finanzen.at) | |
22.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor einem Jahr eingebracht (finanzen.at) | |
21.11.24 |
Gute Stimmung in New York: NASDAQ Composite zum Ende des Donnerstagshandels mit Zuschlägen (finanzen.at) | |
21.11.24 |
Freundlicher Handel: Gewinne im NASDAQ Composite (finanzen.at) | |
21.11.24 |
Anleger in New York halten sich zurück: NASDAQ Composite schwächelt mittags (finanzen.at) | |
21.11.24 |
Börse New York in Rot: NASDAQ Composite beginnt Donnerstagshandel in der Verlustzone (finanzen.at) | |
20.11.24 |
Börse New York in Rot: NASDAQ Composite präsentiert sich zum Handelsende leichter (finanzen.at) | |
20.11.24 |
Handel in New York: NASDAQ Composite verliert am Mittwochnachmittag (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 7,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 218,17 | 0,83% |